Agilent Technologies (A) Financials

$108.83 -4.65 (-4.10%)

Closing price 03:59 PM Eastern

Extended Trading

$108.55 -0.28 (-0.26%)

As of 07:54 PM Eastern

Annual Income Statements for Agilent Technologies

This table shows Agilent Technologies' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	10/31/2024	10/31/2023	10/31/2022	10/31/2021	10/31/2020	10/31/2019	10/31/2018	10/31/2017	10/31/2016	10/31/2015
Net Income / (Loss) Attributable to Common Shareholders	1,289	1,240	1,254	1,210	719	1,071	316	684	462	401
Consolidated Net Income / (Loss)	1,289	1,240	1,254	1,210	719	1,071	316	684	462	401
Net Income / (Loss) Continuing Operations	1,289	1,240	1,254	1,210	719	1,071	316	684	462	438
Total Pre-Tax Income	1,521	1,339	1,504	1,360	842	919	946	803	544	480
Total Operating Income	1,488	1,350	1,618	1,347	846	941	904	807	615	522
Total Gross Profit	3,535	3,465	3,722	3,407	2,837	2,805	2,680	2,399	2,197	2,041
Total Revenue	6,510	6,833	6,848	6,319	5,339	5,163	4,914	4,472	4,202	4,038
Operating Revenue	6,510	6,833	6,848	6,319	5,339	5,163	4,914	4,472	4,202	4,038
Total Cost of Revenue	2,975	3,368	3,126	2,912	2,502	2,358	2,234	2,073	2,005	1,997
Operating Cost of Revenue	2,975	3,368	3,126	2,912	2,502	2,358	2,234	2,073	2,005	1,997
Total Operating Expenses	2,047	2,115	2,104	2,060	1,991	1,864	1,776	1,592	1,582	1,519
Selling, General & Admin Expense	1,568	1,634	1,637	1,619	1,496	1,460	1,389	1,251	1,253	1,189
Research & Development Expense	479	481	467	441	495	404	387	341	329	330
Total Other Income / (Expense), net	33	-11	-114	13	-4.00	-22	42	-4.00	-71	-42
Interest Expense	96	95	84	81	78	74	75	79	72	66
Interest & Investment Income	80	51	9.00	2.00	8.00	36	38	22	11	7.00
Other Income / (Expense), net	49	33	-39	92	66	16	79	53	-10	17
Income Tax Expense	232	99	250	150	123	-152	630	119	82	42
Basic Earnings per Share	$4.44	$4.22	$4.19	$3.98	$2.33	$3.41	$0.98	$2.12	$1.42	$1.20
Weighted Average Basic Shares Outstanding	290M	294M	299M	304M	309M	314M	321M	322M	326M	333M
Diluted Earnings per Share	$4.43	$4.19	$4.18	$3.94	$2.30	$3.37	$0.97	$2.10	$1.40	$1.20
Weighted Average Diluted Shares Outstanding	291M	296M	300M	307M	312M	318M	325M	326M	329M	335M
Weighted Average Basic & Diluted Shares Outstanding	285.60M	293.00M	296.07M	302.00M	306.85M	310.18M	322.40M	322.60M	325.40M	334.20M
Cash Dividends to Common per Share	$0.94	$0.90	$0.84	$0.78	$0.72	$0.66	$0.60	$0.53	$0.46	$0.40

This table shows Agilent Technologies' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	1/31/2025	10/31/2024	7/31/2024	4/30/2024	1/31/2024	10/31/2023	7/31/2023	4/30/2023	1/31/2023	10/31/2022	7/31/2022
Net Income / (Loss) Attributable to Common Shareholders	318	351	282	308	348	475	111	302	352	368	329
Consolidated Net Income / (Loss)	318	351	282	308	348	475	111	302	352	368	329
Net Income / (Loss) Continuing Operations	318	351	282	308	348	475	111	302	352	368	329
Total Pre-Tax Income	367	401	343	374	403	420	132	377	410	455	397
Total Operating Income	376	408	333	363	384	408	133	383	426	471	411
Total Gross Profit	899	916	855	856	908	915	658	924	968	1,012	939
Total Revenue	1,681	1,701	1,578	1,573	1,658	1,688	1,672	1,717	1,756	1,849	1,718
Operating Revenue	1,681	1,701	1,578	1,573	1,658	1,688	1,672	1,717	1,756	1,849	1,718
Total Cost of Revenue	782	785	723	717	750	773	1,014	793	788	837	779
Operating Cost of Revenue	782	785	723	717	750	773	1,014	793	788	837	779
Total Operating Expenses	523	508	522	493	524	507	525	541	542	541	528
Selling, General & Admin Expense	410	397	395	380	396	393	407	415	419	422	412
Research & Development Expense	113	111	127	113	128	114	118	126	123	119	116
Total Other Income / (Expense), net	-9.00	-7.00	10	11	19	12	-1.00	-6.00	-16	-16	-14
Interest Expense	28	32	22	20	22	22	24	24	25	23	19
Interest & Investment Income	15	24	19	19	18	17	13	12	9.00	5.00	2.00
Other Income / (Expense), net	4.00	1.00	13	12	23	17	10	6.00	0.00	2.00	3.00
Income Tax Expense	49	50	61	66	55	-55	21	75	58	87	68
Basic Earnings per Share	$1.12	$1.23	$0.97	$1.05	$1.19	$1.63	$0.38	$1.02	$1.19	$1.23	$1.10
Weighted Average Basic Shares Outstanding	285M	290M	290M	293M	293M	294M	294M	296M	296M	299M	298M
Diluted Earnings per Share	$1.11	$1.23	$0.97	$1.05	$1.18	$1.60	$0.38	$1.02	$1.19	$1.24	$1.10
Weighted Average Diluted Shares Outstanding	287M	291M	291M	293M	294M	296M	295M	297M	297M	300M	299M
Weighted Average Basic & Diluted Shares Outstanding	285.10M	285.60M	287.33M	291.76M	293.06M	293.00M	292.59M	295.38M	295.70M	296.07M	296.04M
Cash Dividends to Common per Share	$0.25	$0.24	$0.24	$0.24	$0.24	$0.23	$0.23	$0.23	$0.23	$0.21	$0.21

This table details how cash moves in and out of Agilent Technologies' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	10/31/2024	10/31/2023	10/31/2022	10/31/2021	10/31/2020	10/31/2019	10/31/2018	10/31/2017	10/31/2016	10/31/2015
Net Change in Cash & Equivalents	-261	537	-434	43	59	-866	-432	391	286	-1,025
Net Cash From Operating Activities	1,751	1,772	1,312	1,485	921	1,021	1,087	889	793	512
Net Cash From Continuing Operating Activities	1,751	1,772	1,312	1,485	921	1,021	1,087	889	793	512
Net Income / (Loss) Continuing Operations	1,289	1,240	1,254	1,210	719	1,071	316	684	462	401
Consolidated Net Income / (Loss)	1,289	1,240	1,254	1,210	719	1,071	316	684	462	401
Depreciation Expense	257	271	317	321	308	238	210	212	246	253
Non-Cash Adjustments To Reconcile Net Income	186	432	236	63	191	97	106	91	112	103
Changes in Operating Assets and Liabilities, net	19	-171	-495	-109	-297	-385	455	-98	-27	-245
Net Cash From Investing Activities	-1,258	-310	-338	-749	-147	-1,590	-705	-304	-238	-400
Net Cash From Continuing Investing Activities	-1,258	-310	-338	-749	-147	-1,590	-705	-304	-238	-400
Purchase of Property, Plant & Equipment	-378	-298	-291	-188	-119	-155	-177	-176	-139	-98
Acquisitions	-862	-51	-52	-547	0.00	-1,409	-516	-128	-261	-75
Purchase of Investments	-5.00	-	-13	-22	-20	-23	-11	-1.00	-80	0.00
Sale of Property, Plant & Equipment	0.00	4.00	0.00	1.00	1.00	0.00	1.00	0.00	0.00	12
Divestitures	0.00	50	0.00	0.00	-	-	-	2.00	0.00	3.00
Sale and/or Maturity of Investments	0.00	5.00	22	12	0.00	0.00	-	-	1.00	0.00
Other Investing Activities, net	-13	-20	-4.00	-5.00	-9.00	-3.00	-2.00	-1.00	241	-242
Net Cash From Financing Activities	-752	-930	-1,372	-696	-717	-299	-797	-202	-268	-1,089
Net Cash From Continuing Financing Activities	-749	-930	-1,372	-696	-717	-299	-797	-202	-268	-1,089
Repayment of Debt	-609	-35	-609	-424	-1,766	-706	-693	-290	-294	0.00
Repurchase of Common Equity	-1,150	-575	-1,139	-788	-469	-723	-422	-194	-434	-267
Payment of Dividends	-274	-265	-250	-236	-222	-210	-191	-170	-150	-133
Issuance of Debt	1,237	0.00	635	773	1,717	1,302	483	400	554	0.00
Issuance of Common Equity	77	67	58	55	60	54	56	66	62	58
Other Financing Activities, net	-30	-122	-67	-76	-37	-16	-30	-14	-6.00	-747
Effect of Exchange Rate Changes	-2.00	-	-36	3.00	2.00	2.00	-17	8.00	-1.00	-48
Cash Interest Paid	80	89	85	76	71	80	80	82	73	71
Cash Income Taxes Paid	314	199	279	211	361	159	102	63	67	129

This table details how cash moves in and out of Agilent Technologies' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	1/31/2025	10/31/2024	7/31/2024	4/30/2024	1/31/2024	10/31/2023	7/31/2023	4/30/2023	1/31/2023	10/31/2022	7/31/2022
Net Change in Cash & Equivalents	138	-450	108	-76	157	261	154	-75	197	-17	-115
Net Cash From Operating Activities	431	481	452	333	485	516	562	398	296	448	326
Net Cash From Continuing Operating Activities	431	481	452	333	485	516	562	398	296	448	326
Net Income / (Loss) Continuing Operations	318	351	282	308	348	475	111	302	352	368	329
Consolidated Net Income / (Loss)	318	351	282	308	348	475	111	302	352	368	329
Depreciation Expense	72	69	63	63	62	62	71	71	67	73	80
Non-Cash Adjustments To Reconcile Net Income	49	46	42	44	54	14	319	37	62	42	42
Changes in Operating Assets and Liabilities, net	-8.00	15	65	-82	21	-35	61	-12	-185	-35	-125
Net Cash From Investing Activities	-94	-954	-100	-109	-95	-40	-89	-77	-104	-110	-73
Net Cash From Continuing Investing Activities	-94	-954	-100	-109	-95	-40	-89	-77	-104	-110	-73
Purchase of Property, Plant & Equipment	-97	-93	-92	-103	-90	-84	-81	-57	-76	-70	-82
Acquisitions	4.00	-859	-3.00	-	0.00	-	-	-21	-30	-34	-
Other Investing Activities, net	-1.00	-2.00	-3.00	-3.00	-5.00	-9.00	-6.00	-2.00	-3.00	-3.00	-
Net Cash From Financing Activities	-180	25	-246	-291	-240	-201	-322	-390	-17	-341	-362
Net Cash From Continuing Financing Activities	-180	28	-246	-291	-240	-201	-322	-390	-17	-341	-362
Repayment of Debt	-31	-429	-	-	-180	-35	-	-	0.00	-	-209
Repurchase of Common Equity	-90	-335	-585	-230	0.00	-80	-335	-85	-75	-135	-323
Payment of Dividends	-71	-68	-68	-69	-69	-66	-66	-66	-67	-62	-62
Issuance of Debt	4.00	862	375	-	0.00	-20	55	-238	203	-145	205
Issuance of Common Equity	30	1.00	33	9.00	34	2.00	30	-	35	3.00	28
Other Financing Activities, net	-22	-3.00	-1.00	-1.00	-25	-2.00	-6.00	-1.00	-113	-2.00	-1.00
Other Net Changes in Cash	-19	-	-	-	7.00	-	-	-	-	-	-
Cash Interest Paid	3.00	30	10	26	14	29	16	29	15	29	16
Cash Income Taxes Paid	19	30	60	200	24	56	15	111	17	62	83

This table presents Agilent Technologies' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	10/31/2024	10/31/2023	10/31/2022	10/31/2021	10/31/2020	10/31/2019	10/31/2018	10/31/2017	10/31/2016	10/31/2015
Total Assets	11,846	10,763	10,532	10,705	9,627	9,452	8,541	8,426	7,794	7,479
Total Current Assets	3,959	4,186	3,778	3,799	3,415	3,189	3,848	4,169	3,635	3,686
Cash & Equivalents	1,329	1,590	1,053	1,484	1,441	1,382	2,247	2,678	2,289	2,003
Accounts Receivable	1,324	1,291	1,405	1,172	1,038	930	776	724	631	606
Inventories, net	972	1,031	1,038	830	720	679	638	575	533	541
Other Current Assets	334	274	282	222	216	198	187	192	182	294
Plant, Property, & Equipment, net	1,778	1,270	1,100	945	845	850	822	757	639	604
Total Noncurrent Assets	6,109	5,307	5,654	5,961	5,367	5,413	3,871	3,500	3,520	3,189
Long-Term Investments	175	164	195	185	158	102	68	138	135	86
Goodwill	4,477	3,960	3,952	3,975	3,602	3,593	2,973	2,607	2,517	2,366
Intangible Assets	547	475	821	981	831	1,107	491	361	416	445
Other Noncurrent Operating Assets	910	708	686	820	776	611	339	394	452	292
Total Liabilities & Shareholders' Equity	11,846	10,763	10,532	10,705	9,627	9,452	8,541	8,426	7,794	7,479
Total Liabilities	5,948	4,918	5,227	5,316	4,754	4,704	3,970	3,591	3,548	3,309
Total Current Liabilities	1,895	1,603	1,861	1,708	1,467	2,080	1,171	1,263	945	976
Short-Term Debt	45	0.00	36	0.00	75	616	0.00	210	0.00	-
Accounts Payable	540	418	580	446	354	354	340	305	257	279
Accrued Expenses	398	-	-	-	-	-	-	-	-	-
Current Deferred Revenue	544	505	461	441	386	336	324	291	269	258
Current Employee Benefit Liabilities	368	371	455	493	367	334	304	276	235	221
Total Noncurrent Liabilities	4,053	3,315	3,366	3,608	3,287	2,624	2,799	2,328	2,603	2,333
Long-Term Debt	3,345	2,735	2,733	2,729	2,284	1,791	1,799	1,801	1,904	1,655
Noncurrent Employee Benefit Liabilities	130	103	97	220	389	360	239	234	360	264
Other Noncurrent Operating Liabilities	578	477	536	659	614	473	761	293	339	414
Commitments & Contingencies	0.00	0.00	0.00	0.00	-	0.00	-	-	-	-
Total Equity & Noncontrolling Interests	5,898	5,845	5,305	5,389	4,873	4,748	4,571	4,835	4,246	4,170
Total Preferred & Common Equity	5,898	5,845	5,305	5,389	4,873	4,748	4,567	4,831	4,243	4,167
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	5,898	5,845	5,305	5,389	4,873	4,748	4,567	4,831	4,243	4,167
Common Stock	5,453	5,390	5,328	5,323	5,314	5,280	5,311	5,303	9,165	9,051
Retained Earnings	750	782	324	348	81	-18	-336	-126	6,089	5,581
Accumulated Other Comprehensive Income / (Loss)	-305	-327	-347	-282	-522	-514	-408	-346	-503	-391

This table presents Agilent Technologies' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	1/31/2025	10/31/2024	7/31/2024	4/30/2024	1/31/2024	10/31/2023	7/31/2023	4/30/2023	1/31/2023	10/31/2022	7/31/2022
Total Assets	11,914	11,846	10,996	10,856	10,948	10,763	10,675	10,792	10,919	10,532	10,484
Total Current Assets	4,107	3,959	4,256	4,203	4,338	4,186	4,030	3,949	4,078	3,778	3,690
Cash & Equivalents	1,467	1,329	1,779	1,671	1,748	1,590	1,329	1,175	1,250	1,053	1,071
Accounts Receivable	1,328	1,324	1,227	1,249	1,295	1,291	1,339	1,401	1,459	1,405	1,345
Inventories, net	997	972	978	1,000	1,033	1,031	1,072	1,103	1,111	1,038	1,010
Other Current Assets	315	334	272	283	262	274	290	270	258	282	258
Plant, Property, & Equipment, net	1,816	1,778	1,446	1,371	1,314	1,270	1,211	1,184	1,147	1,100	1,054
Total Noncurrent Assets	5,991	6,109	5,294	5,282	5,296	5,307	5,434	5,659	5,694	5,654	5,740
Long-Term Investments	173	175	186	177	170	164	190	186	188	195	194
Goodwill	4,429	4,477	3,965	3,963	3,967	3,960	3,984	3,980	3,983	3,952	3,948
Intangible Assets	514	547	392	417	443	475	502	798	810	821	849
Other Noncurrent Operating Assets	875	910	751	725	716	708	758	695	713	686	749
Total Liabilities & Shareholders' Equity	11,914	11,846	10,996	10,856	10,948	10,763	10,675	10,792	10,919	10,532	10,484
Total Liabilities	5,887	5,948	5,093	4,642	4,760	4,918	5,117	5,011	5,310	5,227	5,393
Total Current Liabilities	1,869	1,895	2,389	1,958	1,617	1,603	1,760	1,666	1,936	1,861	1,902
Short-Term Debt	16	45	795	420	-	0.00	55	0.00	238	36	180
Accounts Payable	547	540	497	461	488	418	452	479	540	580	558
Accrued Expenses	436	398	264	218	335	-	410	309	341	-	277
Current Deferred Revenue	612	544	524	533	522	505	512	519	521	461	498
Current Employee Benefit Liabilities	258	368	309	326	272	371	331	359	296	455	389
Total Noncurrent Liabilities	4,018	4,053	2,704	2,684	3,143	3,315	3,357	3,345	3,374	3,366	3,491
Long-Term Debt	3,347	3,345	2,137	2,136	2,555	2,735	2,734	2,733	2,733	2,733	2,732
Noncurrent Employee Benefit Liabilities	120	130	96	99	102	103	92	97	99	97	176
Other Noncurrent Operating Liabilities	551	578	471	449	486	477	531	515	542	536	583
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	6,027	5,898	5,903	6,214	6,188	5,845	5,558	5,781	5,609	5,305	5,091
Total Preferred & Common Equity	6,027	5,898	5,903	6,214	6,188	5,845	5,558	5,781	5,609	5,305	5,091
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	6,027	5,898	5,903	6,214	6,188	5,845	5,558	5,781	5,609	5,305	5,091
Common Stock	5,492	5,453	5,461	5,461	5,443	5,390	5,385	5,363	5,348	5,328	5,314
Retained Earnings	916	750	773	1,090	1,061	782	444	700	541	324	139
Accumulated Other Comprehensive Income / (Loss)	-381	-305	-331	-337	-316	-327	-271	-282	-280	-347	-362

This table displays calculated financial ratios and metrics derived from Agilent Technologies' official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	10/31/2024	10/31/2023	10/31/2022	10/31/2021	10/31/2020	10/31/2019	10/31/2018	10/31/2017	10/31/2016	10/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-4.73%	-0.22%	8.37%	18.36%	3.41%	5.07%	9.88%	6.43%	4.06%	-0.25%
EBITDA Growth	8.46%	-12.76%	7.73%	44.26%	2.09%	0.17%	11.29%	25.97%	7.45%	14.45%
EBIT Growth	11.14%	-12.41%	9.73%	57.79%	-4.70%	-2.65%	14.30%	42.15%	12.24%	63.33%
NOPAT Growth	0.87%	-7.33%	12.57%	65.89%	-34.12%	263.16%	-56.07%	31.61%	9.65%	12.21%
Net Income Growth	3.95%	-1.12%	3.64%	68.29%	-32.87%	238.92%	-53.80%	48.05%	15.21%	-26.96%
EPS Growth	5.73%	0.24%	6.09%	71.30%	-31.75%	247.42%	-53.81%	50.00%	16.67%	-25.93%
Operating Cash Flow Growth	-1.19%	35.06%	-11.65%	61.24%	-9.79%	-6.07%	22.27%	12.11%	54.88%	-29.96%
Free Cash Flow Firm Growth	-75.76%	41.90%	86.10%	-37.74%	246.41%	-287.52%	-27.76%	32.07%	-59.07%	-62.10%
Invested Capital Growth	14.03%	0.00%	7.36%	12.87%	-0.67%	39.85%	0.62%	8.16%	6.64%	-6.25%
Revenue Q/Q Growth	0.20%	-2.30%	2.84%	2.88%	2.22%	1.43%	2.18%	1.78%	1.84%	-0.20%
EBITDA Q/Q Growth	-0.50%	-3.44%	-0.32%	11.04%	4.72%	1.19%	1.45%	6.77%	0.59%	18.92%
EBIT Q/Q Growth	-1.03%	-3.35%	0.32%	13.13%	6.42%	-0.62%	1.34%	9.14%	1.51%	41.84%
NOPAT Q/Q Growth	-7.64%	7.30%	-1.38%	15.64%	3.63%	1.97%	9.47%	-0.05%	0.02%	12.46%
Net Income Q/Q Growth	-8.78%	9.44%	-5.57%	22.22%	4.05%	-0.09%	6.04%	8.06%	-2.94%	21.88%
EPS Q/Q Growth	-7.71%	9.40%	-4.78%	23.13%	3.60%	0.90%	6.59%	6.60%	-4.11%	21.21%
Operating Cash Flow Q/Q Growth	-1.96%	3.99%	0.54%	4.50%	7.34%	-5.38%	8.37%	6.47%	-0.88%	12.53%
Free Cash Flow Firm Q/Q Growth	-77.10%	16.93%	9.05%	-28.53%	281.10%	-192.67%	171.96%	-33.29%	20.37%	-66.64%
Invested Capital Q/Q Growth	13.30%	-0.03%	1.40%	3.01%	-2.85%	21.15%	-2.66%	0.95%	-3.94%	-2.89%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	54.30%	50.71%	54.35%	53.92%	53.14%	54.33%	54.54%	53.64%	52.28%	50.54%
EBITDA Margin	27.56%	24.21%	27.69%	27.85%	22.85%	23.15%	24.28%	23.97%	20.25%	19.61%
Operating Margin	22.86%	19.76%	23.63%	21.32%	15.85%	18.23%	18.40%	18.05%	14.64%	12.93%
EBIT Margin	23.61%	20.24%	23.06%	22.77%	17.08%	18.54%	20.00%	19.23%	14.40%	13.35%
Profit (Net Income) Margin	19.80%	18.15%	18.31%	19.15%	13.47%	20.74%	6.43%	15.30%	10.99%	9.93%
Tax Burden Percent	84.75%	92.61%	83.38%	88.97%	85.39%	116.54%	33.40%	85.18%	84.93%	83.54%
Interest Burden Percent	98.96%	96.82%	95.25%	94.51%	92.32%	96.03%	96.24%	93.37%	89.92%	89.05%
Effective Tax Rate	15.25%	7.39%	16.62%	11.03%	14.61%	-16.54%	66.60%	14.82%	15.07%	8.75%
Return on Invested Capital (ROIC)	17.26%	18.32%	20.47%	19.99%	12.78%	22.55%	7.47%	17.73%	14.47%	13.19%
ROIC Less NNEP Spread (ROIC-NNEP)	19.21%	17.50%	12.83%	21.33%	12.38%	9.95%	5.35%	18.24%	24.55%	19.88%
Return on Net Nonoperating Assets (RNNOA)	4.69%	3.93%	2.99%	3.59%	2.16%	0.43%	-0.75%	-2.66%	-3.49%	-4.73%
Return on Equity (ROE)	21.95%	22.24%	23.45%	23.58%	14.95%	22.99%	6.72%	15.06%	10.98%	8.47%
Cash Return on Invested Capital (CROIC)	4.15%	18.32%	13.37%	7.90%	13.45%	-10.68%	6.85%	9.89%	8.04%	19.65%
Operating Return on Assets (OROA)	13.60%	12.99%	14.87%	14.16%	9.56%	10.64%	11.59%	10.60%	7.92%	5.89%
Return on Assets (ROA)	11.40%	11.65%	11.81%	11.90%	7.54%	11.90%	3.72%	8.43%	6.05%	4.38%
Return on Common Equity (ROCE)	21.95%	22.24%	23.45%	23.58%	14.95%	22.98%	6.71%	15.05%	10.97%	8.46%
Return on Equity Simple (ROE_SIMPLE)	21.85%	21.21%	23.64%	22.45%	14.75%	22.56%	6.92%	14.16%	10.89%	9.62%
Net Operating Profit after Tax (NOPAT)	1,261	1,250	1,349	1,198	722	1,097	302	687	522	476
NOPAT Margin	19.37%	18.30%	19.70%	18.97%	13.53%	21.24%	6.15%	15.37%	12.43%	11.80%
Net Nonoperating Expense Percent (NNEP)	-1.95%	0.81%	7.63%	-1.34%	0.41%	12.60%	2.12%	-0.51%	-10.08%	-6.69%
Return On Investment Capital (ROIC_SIMPLE)	13.58%	14.57%	16.71%	14.76%	9.99%	15.33%	4.74%	10.04%	8.49%	8.18%
Cost of Revenue to Revenue	45.70%	49.29%	45.65%	46.08%	46.86%	45.67%	45.46%	46.36%	47.72%	49.46%
SG&A Expenses to Revenue	24.09%	23.91%	23.90%	25.62%	28.02%	28.28%	28.27%	27.97%	29.82%	29.45%
R&D to Revenue	7.36%	7.04%	6.82%	6.98%	9.27%	7.82%	7.88%	7.63%	7.83%	8.17%
Operating Expenses to Revenue	31.44%	30.95%	30.72%	32.60%	37.29%	36.10%	36.14%	35.60%	37.65%	37.62%
Earnings before Interest and Taxes (EBIT)	1,537	1,383	1,579	1,439	912	957	983	860	605	539
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	1,794	1,654	1,896	1,760	1,220	1,195	1,193	1,072	851	792
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	6.34	5.13	7.60	8.65	6.28	4.76	4.32	4.29	3.13	2.79
Price to Tangible Book Value (P/TBV)	42.76	21.27	75.79	107.71	69.58	470.97	17.90	11.13	10.12	8.57
Price to Revenue (P/Rev)	5.74	4.39	5.89	7.38	5.73	4.38	4.02	4.64	3.16	2.88
Price to Earnings (P/E)	28.99	24.18	32.15	38.54	42.58	21.11	62.47	30.32	28.70	28.97
Dividend Yield	0.73%	0.88%	0.62%	0.50%	0.73%	0.90%	0.96%	0.82%	1.13%	1.14%
Earnings Yield	3.45%	4.14%	3.11%	2.59%	2.35%	4.74%	1.60%	3.30%	3.48%	3.45%
Enterprise Value to Invested Capital (EV/IC)	5.04	4.54	6.13	7.49	5.57	4.15	4.74	4.95	3.42	3.13
Enterprise Value to Revenue (EV/Rev)	6.03	4.53	6.11	7.53	5.88	4.56	3.91	4.46	3.03	2.71
Enterprise Value to EBITDA (EV/EBITDA)	21.88	18.72	22.07	27.05	25.72	19.69	16.12	18.60	14.97	13.82
Enterprise Value to EBIT (EV/EBIT)	25.54	22.39	26.50	33.08	34.40	24.59	19.56	23.19	21.06	20.30
Enterprise Value to NOPAT (EV/NOPAT)	31.13	24.77	31.02	39.72	43.43	21.46	63.68	29.01	24.40	22.97
Enterprise Value to Operating Cash Flow (EV/OCF)	22.42	17.48	31.89	32.06	34.07	23.05	17.69	22.43	16.07	21.37
Enterprise Value to Free Cash Flow (EV/FCFF)	129.55	24.77	47.49	100.55	41.26	0.00	69.43	52.01	43.90	15.43
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.57	0.47	0.52	0.51	0.48	0.51	0.39	0.42	0.45	0.40
Long-Term Debt to Equity	0.57	0.47	0.52	0.51	0.47	0.38	0.39	0.37	0.45	0.40
Financial Leverage	0.24	0.22	0.23	0.17	0.17	0.04	-0.14	-0.15	-0.14	-0.24
Leverage Ratio	1.93	1.91	1.99	1.98	1.98	1.93	1.80	1.79	1.81	1.93
Compound Leverage Factor	1.91	1.85	1.89	1.87	1.83	1.85	1.74	1.67	1.63	1.72
Debt to Total Capital	36.50%	31.88%	34.30%	33.62%	32.62%	33.64%	28.24%	29.37%	30.96%	28.41%
Short-Term Debt to Total Capital	0.48%	0.00%	0.45%	0.00%	1.04%	8.61%	0.00%	3.07%	0.00%	0.00%
Long-Term Debt to Total Capital	36.01%	31.88%	33.85%	33.62%	31.58%	25.03%	28.24%	26.31%	30.96%	28.41%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.06%	0.06%	0.05%	0.05%
Common Equity to Total Capital	63.50%	68.12%	65.70%	66.38%	67.38%	66.36%	71.70%	70.57%	68.99%	71.54%
Debt to EBITDA	1.89	1.65	1.46	1.55	1.93	2.01	1.51	1.88	2.24	2.09
Net Debt to EBITDA	1.05	0.59	0.80	0.55	0.62	0.77	-0.43	-0.75	-0.61	-0.85
Long-Term Debt to EBITDA	1.86	1.65	1.44	1.55	1.87	1.50	1.51	1.68	2.24	2.09
Debt to NOPAT	2.69	2.19	2.05	2.28	3.27	2.19	5.96	2.93	3.65	3.47
Net Debt to NOPAT	1.50	0.78	1.13	0.81	1.05	0.84	-1.71	-1.17	-1.00	-1.42
Long-Term Debt to NOPAT	2.65	2.19	2.03	2.28	3.16	1.63	5.96	2.62	3.65	3.47
Altman Z-Score	5.05	5.11	6.03	6.58	4.99	3.90	4.26	4.73	4.55	4.36
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.04%	0.09%	0.08%	0.07%	0.06%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.09	2.61	2.03	2.22	2.33	1.53	3.29	3.30	3.85	3.78
Quick Ratio	1.40	1.80	1.32	1.61	1.69	1.11	2.58	2.69	3.09	2.67
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	303	1,250	881	473	760	-519	277	383	290	709
Operating Cash Flow to CapEx	463.23%	602.72%	450.86%	794.12%	780.51%	658.71%	617.61%	505.11%	570.50%	595.35%
Free Cash Flow to Firm to Interest Expense	3.16	13.16	10.49	5.84	9.75	-7.02	3.69	4.85	4.03	10.75
Operating Cash Flow to Interest Expense	18.24	18.65	15.62	18.33	11.81	13.80	14.49	11.25	11.01	7.76
Operating Cash Flow Less CapEx to Interest Expense	14.30	15.56	12.15	16.02	10.29	11.70	12.15	9.03	9.08	6.45
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.58	0.64	0.64	0.62	0.56	0.57	0.58	0.55	0.55	0.44
Accounts Receivable Turnover	4.98	5.07	5.31	5.72	5.43	6.05	6.55	6.60	6.79	6.56
Inventory Turnover	2.97	3.26	3.35	3.76	3.58	3.58	3.68	3.74	3.73	3.58
Fixed Asset Turnover	4.27	5.77	6.70	7.06	6.30	6.18	6.22	6.41	6.76	6.54
Accounts Payable Turnover	6.21	6.75	6.09	7.28	7.07	6.80	6.93	7.38	7.48	6.87
Days Sales Outstanding (DSO)	73.31	72.01	68.68	63.83	67.27	60.30	55.71	55.30	53.73	55.68
Days Inventory Outstanding (DIO)	122.87	112.11	109.06	97.14	102.05	101.93	99.09	97.54	97.76	101.90
Days Payable Outstanding (DPO)	58.77	54.08	59.90	50.14	51.64	53.71	52.69	49.48	48.79	53.10
Cash Conversion Cycle (CCC)	137.41	130.04	117.83	110.83	117.67	108.52	102.11	103.36	102.70	104.48
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	7,784	6,826	6,826	6,358	5,633	5,671	4,055	4,030	3,726	3,494
Invested Capital Turnover	0.89	1.00	1.04	1.05	0.94	1.06	1.22	1.15	1.16	1.12
Increase / (Decrease) in Invested Capital	958	0.00	468	725	-38	1,616	25	304	232	-233
Enterprise Value (EV)	39,259	30,967	41,842	47,606	31,374	23,530	19,229	19,939	12,743	10,942
Market Capitalization	37,373	29,986	40,321	46,637	30,614	22,607	19,741	20,740	13,260	11,615
Book Value per Share	$20.53	$19.98	$17.92	$17.80	$15.81	$15.34	$14.33	$15.01	$13.08	$12.57
Tangible Book Value per Share	$3.04	$4.82	$1.80	$1.43	$1.43	$0.16	$3.46	$5.79	$4.04	$4.09
Total Capital	9,288	8,580	8,074	8,118	7,232	7,155	6,370	6,846	6,150	5,825
Total Debt	3,390	2,735	2,769	2,729	2,359	2,407	1,799	2,011	1,904	1,655
Total Long-Term Debt	3,345	2,735	2,733	2,729	2,284	1,791	1,799	1,801	1,904	1,655
Net Debt	1,886	981	1,521	969	760	923	-516	-805	-520	-676
Capital Expenditures (CapEx)	378	294	291	187	118	155	176	176	139	86
Debt-free, Cash-free Net Working Capital (DFCFNWC)	780	993	900	516	582	343	430	438	401	465
Debt-free Net Working Capital (DFNWC)	2,109	2,583	1,953	2,091	2,023	1,725	2,677	3,116	2,690	2,710
Net Working Capital (NWC)	2,064	2,583	1,917	2,091	1,948	1,109	2,677	2,906	2,690	2,710
Net Nonoperating Expense (NNE)	-28	10	95	-12	3.42	26	-14	3.41	60	75
Net Nonoperating Obligations (NNO)	1,886	981	1,521	969	760	923	-516	-805	-520	-676
Total Depreciation and Amortization (D&A)	257	271	317	321	308	238	210	212	246	253
Debt-free, Cash-free Net Working Capital to Revenue	11.98%	14.53%	13.14%	8.17%	10.90%	6.64%	8.75%	9.79%	9.54%	11.52%
Debt-free Net Working Capital to Revenue	32.40%	37.80%	28.52%	33.09%	37.89%	33.41%	54.48%	69.68%	64.02%	67.11%
Net Working Capital to Revenue	31.71%	37.80%	27.99%	33.09%	36.49%	21.48%	54.48%	64.98%	64.02%	67.11%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$4.44	$4.22	$4.19	$3.98	$2.33	$3.41	$0.98	$2.12	$1.42	$1.20
Adjusted Weighted Average Basic Shares Outstanding	290M	294M	299M	304M	309M	314M	321M	322M	326M	333M
Adjusted Diluted Earnings per Share	$4.43	$4.19	$4.18	$3.94	$2.30	$3.37	$0.97	$2.10	$1.40	$1.20
Adjusted Weighted Average Diluted Shares Outstanding	291M	296M	300M	307M	312M	318M	325M	326M	329M	335M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$3.41	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	285.60M	293.00M	296.07M	302.00M	306.85M	310.18M	318.53M	323.02M	321.75M	332.17M
Normalized Net Operating Profit after Tax (NOPAT)	1,261	1,250	1,349	1,198	722	659	633	687	522	476
Normalized NOPAT Margin	19.37%	18.30%	19.70%	18.97%	13.53%	12.76%	12.88%	15.37%	12.43%	11.80%
Pre Tax Income Margin	23.36%	19.60%	21.96%	21.52%	15.77%	17.80%	19.25%	17.96%	12.95%	11.89%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	16.01	14.56	18.80	17.77	11.69	12.93	13.11	10.89	8.40	8.17
NOPAT to Interest Expense	13.14	13.16	16.06	14.80	9.26	14.82	4.03	8.70	7.25	7.22
EBIT Less CapEx to Interest Expense	12.07	11.46	15.33	15.46	10.18	10.84	10.76	8.66	6.47	6.86
NOPAT Less CapEx to Interest Expense	9.20	10.07	12.60	12.49	7.75	12.72	1.68	6.47	5.32	5.91
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	21.26%	21.37%	19.94%	19.50%	30.88%	19.61%	60.44%	24.85%	32.47%	33.17%
Augmented Payout Ratio	110.47%	67.74%	110.77%	84.63%	96.11%	87.11%	193.99%	53.22%	126.41%	99.75%

This table displays calculated financial ratios and metrics derived from Agilent Technologies' official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	1/31/2025	10/31/2024	7/31/2024	4/30/2024	1/31/2024	10/31/2023	7/31/2023	4/30/2023	1/31/2023	10/31/2022	7/31/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	1.39%	0.77%	-5.62%	-8.39%	-5.58%	-8.71%	-2.68%	6.85%	4.90%	11.39%	8.32%
EBITDA Growth	-3.62%	-1.85%	91.12%	-4.78%	-4.87%	-10.81%	-56.68%	5.75%	17.10%	-1.09%	14.35%
EBIT Growth	-6.63%	-3.76%	141.96%	-3.60%	-4.46%	-10.15%	-65.46%	10.20%	25.66%	1.07%	18.97%
NOPAT Growth	-1.75%	-22.60%	144.79%	-2.56%	-9.34%	21.13%	-67.16%	3.58%	9.64%	-2.25%	25.56%
Net Income Growth	-8.62%	-26.11%	154.05%	1.99%	-1.14%	29.08%	-66.26%	10.22%	24.38%	-16.74%	24.62%
EPS Growth	-5.93%	-23.13%	155.26%	2.94%	-0.84%	29.03%	-65.45%	12.09%	27.96%	-14.48%	27.91%
Operating Cash Flow Growth	-11.13%	-6.78%	-19.57%	-16.33%	63.85%	15.18%	72.39%	40.64%	16.08%	1.59%	-2.40%
Free Cash Flow Firm Growth	-192.38%	-230.22%	1,363.16%	345.12%	368.83%	630.02%	107.22%	-35.30%	38.52%	74.03%	-113.56%
Invested Capital Growth	13.55%	14.03%	0.62%	-3.23%	-4.44%	0.00%	1.43%	7.89%	9.29%	7.36%	9.07%
Revenue Q/Q Growth	-1.18%	7.79%	0.32%	-5.13%	-1.78%	0.96%	-2.62%	-2.22%	-5.03%	7.63%	6.91%
EBITDA Q/Q Growth	-5.44%	16.87%	-6.62%	-6.61%	-3.70%	127.57%	-53.48%	-6.69%	-9.71%	10.53%	13.56%
EBIT Q/Q Growth	-7.09%	18.21%	-7.73%	-7.86%	-4.24%	197.20%	-63.24%	-8.69%	-9.94%	14.25%	17.28%
NOPAT Q/Q Growth	-8.77%	30.44%	-8.42%	-9.85%	-28.14%	312.58%	-63.55%	-16.11%	-3.99%	11.84%	14.98%
Net Income Q/Q Growth	-9.40%	24.47%	-8.44%	-11.49%	-26.74%	327.93%	-63.25%	-14.20%	-4.35%	11.85%	20.07%
EPS Q/Q Growth	-9.76%	26.80%	-7.62%	-11.02%	-26.25%	321.05%	-62.75%	-14.29%	-4.03%	12.73%	20.88%
Operating Cash Flow Q/Q Growth	-10.40%	6.42%	35.74%	-31.34%	-6.01%	-8.19%	41.21%	34.46%	-33.93%	37.42%	15.19%
Free Cash Flow Firm Q/Q Growth	0.28%	-359.24%	-56.26%	-18.29%	40.56%	2,812.89%	107.33%	10.39%	-177.13%	60.32%	-37.31%
Invested Capital Q/Q Growth	-0.44%	13.30%	-0.75%	1.42%	-0.01%	-0.03%	-4.54%	0.15%	4.63%	1.40%	1.54%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	53.48%	53.85%	54.18%	54.42%	54.76%	54.21%	39.35%	53.81%	55.13%	54.73%	54.66%
EBITDA Margin	26.89%	28.10%	25.92%	27.84%	28.29%	28.85%	12.80%	26.79%	28.08%	29.53%	28.75%
Operating Margin	22.37%	23.99%	21.10%	23.08%	23.16%	24.17%	7.95%	22.31%	24.26%	25.47%	23.92%
EBIT Margin	22.61%	24.04%	21.93%	23.84%	24.55%	25.18%	8.55%	22.66%	24.26%	25.58%	24.10%
Profit (Net Income) Margin	18.92%	20.63%	17.87%	19.58%	20.99%	28.14%	6.64%	17.59%	20.05%	19.90%	19.15%
Tax Burden Percent	86.65%	87.53%	82.22%	82.35%	86.35%	113.10%	84.09%	80.11%	85.85%	80.88%	82.87%
Interest Burden Percent	96.58%	98.04%	99.13%	99.73%	99.02%	98.82%	92.31%	96.92%	96.24%	96.19%	95.89%
Effective Tax Rate	13.35%	12.47%	17.78%	17.65%	13.65%	-13.10%	15.91%	19.89%	14.15%	19.12%	17.13%
Return on Invested Capital (ROIC)	17.37%	18.71%	16.46%	17.80%	19.29%	27.36%	6.90%	18.25%	21.11%	21.40%	20.46%
ROIC Less NNEP Spread (ROIC-NNEP)	16.71%	18.28%	17.19%	18.67%	20.80%	28.45%	6.84%	17.92%	20.16%	20.36%	19.65%
Return on Net Nonoperating Assets (RNNOA)	3.23%	4.46%	3.36%	3.24%	3.83%	6.38%	1.87%	4.73%	5.46%	4.74%	5.61%
Return on Equity (ROE)	20.60%	23.17%	19.81%	21.04%	23.11%	33.75%	8.77%	22.99%	26.57%	26.14%	26.08%
Cash Return on Invested Capital (CROIC)	4.53%	4.15%	19.32%	20.39%	21.92%	18.32%	15.77%	12.64%	11.36%	13.37%	12.52%
Operating Return on Assets (OROA)	12.92%	13.85%	13.15%	14.52%	15.12%	16.16%	5.65%	15.01%	15.83%	16.50%	15.30%
Return on Assets (ROA)	10.81%	11.88%	10.72%	11.92%	12.93%	18.06%	4.39%	11.66%	13.08%	12.84%	12.16%
Return on Common Equity (ROCE)	20.60%	23.17%	19.81%	21.04%	23.11%	33.75%	8.77%	22.99%	26.57%	26.14%	26.08%
Return on Equity Simple (ROE_SIMPLE)	20.89%	0.00%	23.94%	19.99%	19.97%	0.00%	20.39%	23.37%	23.59%	0.00%	26.09%
Net Operating Profit after Tax (NOPAT)	326	357	274	299	332	461	112	307	366	381	341
NOPAT Margin	19.38%	21.00%	17.35%	19.00%	20.00%	27.34%	6.69%	17.87%	20.83%	20.60%	19.83%
Net Nonoperating Expense Percent (NNEP)	0.66%	0.43%	-0.74%	-0.87%	-1.51%	-1.08%	0.06%	0.33%	0.94%	1.04%	0.81%
Return On Investment Capital (ROIC_SIMPLE)	3.47%	3.85%	3.10%	3.41%	3.79%	5.38%	1.34%	3.60%	4.26%	4.72%	4.26%
Cost of Revenue to Revenue	46.52%	46.15%	45.82%	45.58%	45.24%	45.79%	60.65%	46.19%	44.87%	45.27%	45.34%
SG&A Expenses to Revenue	24.39%	23.34%	25.03%	24.16%	23.88%	23.28%	24.34%	24.17%	23.86%	22.82%	23.98%
R&D to Revenue	6.72%	6.53%	8.05%	7.18%	7.72%	6.75%	7.06%	7.34%	7.00%	6.44%	6.75%
Operating Expenses to Revenue	31.11%	29.86%	33.08%	31.34%	31.60%	30.04%	31.40%	31.51%	30.87%	29.26%	30.73%
Earnings before Interest and Taxes (EBIT)	380	409	346	375	407	425	143	389	426	473	414
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	452	478	409	438	469	487	214	460	493	546	494
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	7.16	6.34	6.96	6.43	6.11	5.13	6.40	6.84	7.91	7.60	7.73
Price to Tangible Book Value (P/TBV)	39.84	42.76	26.59	21.78	21.26	21.27	33.20	39.43	54.40	75.79	133.90
Price to Revenue (P/Rev)	6.61	5.74	6.33	6.06	5.61	4.39	5.09	5.62	6.41	5.89	5.91
Price to Earnings (P/E)	34.30	28.99	29.10	32.16	30.59	24.18	31.41	29.27	33.56	32.15	29.64
Dividend Yield	0.63%	0.73%	0.66%	0.68%	0.71%	0.88%	0.73%	0.65%	0.57%	0.62%	0.63%
Earnings Yield	2.92%	3.45%	3.44%	3.11%	3.27%	4.14%	3.18%	3.42%	2.98%	3.11%	3.37%
Enterprise Value to Invested Capital (EV/IC)	5.79	5.04	6.13	5.87	5.63	4.54	5.40	5.72	6.43	6.13	6.09
Enterprise Value to Revenue (EV/Rev)	6.87	6.03	6.48	6.17	5.71	4.53	5.27	5.81	6.63	6.11	6.16
Enterprise Value to EBITDA (EV/EBITDA)	25.27	21.88	23.34	25.28	23.58	18.72	21.52	20.53	23.34	22.07	21.56
Enterprise Value to EBIT (EV/EBIT)	29.74	25.54	27.10	30.12	28.18	22.39	25.76	24.04	27.57	26.50	26.05
Enterprise Value to NOPAT (EV/NOPAT)	35.79	31.13	30.82	33.78	31.67	24.77	31.63	29.36	33.19	31.02	29.98
Enterprise Value to Operating Cash Flow (EV/OCF)	26.46	22.42	23.56	21.44	19.60	17.48	21.63	27.87	33.94	31.89	31.42
Enterprise Value to Free Cash Flow (EV/FCFF)	136.17	129.55	31.80	28.34	25.11	24.77	34.47	46.99	59.14	47.49	50.76
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.56	0.57	0.50	0.41	0.41	0.47	0.50	0.47	0.53	0.52	0.57
Long-Term Debt to Equity	0.56	0.57	0.36	0.34	0.41	0.47	0.49	0.47	0.49	0.52	0.54
Financial Leverage	0.19	0.24	0.20	0.17	0.18	0.22	0.27	0.26	0.27	0.23	0.29
Leverage Ratio	1.87	1.93	1.89	1.80	1.85	1.91	1.99	1.95	1.97	1.99	2.09
Compound Leverage Factor	1.81	1.89	1.87	1.80	1.84	1.89	1.83	1.89	1.90	1.91	2.00
Debt to Total Capital	35.81%	36.50%	33.19%	29.14%	29.22%	31.88%	33.41%	32.10%	34.63%	34.30%	36.39%
Short-Term Debt to Total Capital	0.17%	0.48%	9.00%	4.79%	0.00%	0.00%	0.66%	0.00%	2.77%	0.45%	2.25%
Long-Term Debt to Total Capital	35.64%	36.01%	24.19%	24.36%	29.22%	31.88%	32.75%	32.10%	31.85%	33.85%	34.14%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	64.19%	63.50%	66.81%	70.86%	70.78%	68.12%	66.59%	67.90%	65.37%	65.70%	63.61%
Debt to EBITDA	1.89	1.89	1.63	1.59	1.57	1.65	1.63	1.37	1.51	1.46	1.53
Net Debt to EBITDA	0.97	1.05	0.54	0.44	0.39	0.59	0.74	0.69	0.78	0.80	0.86
Long-Term Debt to EBITDA	1.88	1.86	1.19	1.33	1.57	1.65	1.60	1.37	1.39	1.44	1.44
Debt to NOPAT	2.68	2.69	2.15	2.12	2.11	2.19	2.39	1.96	2.15	2.05	2.13
Net Debt to NOPAT	1.37	1.50	0.71	0.59	0.52	0.78	1.09	0.98	1.11	1.13	1.20
Long-Term Debt to NOPAT	2.67	2.65	1.57	1.77	2.11	2.19	2.35	1.96	1.98	2.03	2.00
Altman Z-Score	5.39	4.73	5.84	6.27	5.94	4.81	5.19	5.85	6.08	5.69	5.37
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.20	2.09	1.78	2.15	2.68	2.61	2.29	2.37	2.11	2.03	1.94
Quick Ratio	1.50	1.40	1.26	1.49	1.88	1.80	1.52	1.55	1.40	1.32	1.27
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-599	-601	232	530	649	461	16	-216	-241	-87	-219
Operating Cash Flow to CapEx	444.33%	517.20%	491.30%	323.30%	538.89%	614.29%	693.83%	698.25%	389.47%	640.00%	397.56%
Free Cash Flow to Firm to Interest Expense	-21.40	-18.78	10.54	26.50	29.48	20.97	0.66	-9.01	-9.65	-3.79	-11.55
Operating Cash Flow to Interest Expense	15.39	15.03	20.55	16.65	22.05	23.45	23.42	16.58	11.84	19.48	17.16
Operating Cash Flow Less CapEx to Interest Expense	11.93	12.13	16.36	11.50	17.95	19.64	20.04	14.21	8.80	16.43	12.84
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.57	0.58	0.60	0.61	0.62	0.64	0.66	0.66	0.65	0.64	0.63
Accounts Receivable Turnover	4.98	4.98	5.06	4.97	4.89	5.07	5.21	5.34	5.20	5.31	5.40
Inventory Turnover	2.96	2.97	2.89	3.09	3.11	3.26	3.30	3.13	3.17	3.35	3.34
Fixed Asset Turnover	4.17	4.27	4.89	5.16	5.47	5.77	6.18	6.42	6.53	6.70	6.80
Accounts Payable Turnover	5.81	6.21	6.24	6.92	6.48	6.75	6.80	6.51	6.21	6.09	6.26
Days Sales Outstanding (DSO)	73.27	73.31	72.08	73.38	74.63	72.01	70.04	68.39	70.16	68.68	67.61
Days Inventory Outstanding (DIO)	123.20	122.87	126.27	117.95	117.50	112.11	110.71	116.45	115.29	109.06	109.42
Days Payable Outstanding (DPO)	62.82	58.77	58.45	52.72	56.34	54.08	53.71	56.06	58.81	59.90	58.30
Cash Conversion Cycle (CCC)	133.66	137.41	139.89	138.60	135.79	130.04	127.04	128.78	126.64	117.83	118.73
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	7,750	7,784	6,870	6,922	6,825	6,826	6,828	7,153	7,142	6,826	6,732
Invested Capital Turnover	0.90	0.89	0.95	0.94	0.96	1.00	1.03	1.02	1.01	1.04	1.03
Increase / (Decrease) in Invested Capital	925	958	42	-231	-317	0.00	96	523	607	468	560
Enterprise Value (EV)	44,905	39,259	42,080	40,656	38,440	30,967	36,858	40,920	45,927	41,842	41,008
Market Capitalization	43,182	37,373	41,113	39,948	37,803	29,986	35,588	39,548	44,394	40,321	39,367
Book Value per Share	$21.10	$20.53	$20.23	$21.20	$21.12	$19.98	$18.82	$19.55	$18.94	$17.92	$17.04
Tangible Book Value per Share	$3.80	$3.04	$5.30	$6.26	$6.07	$4.82	$3.63	$3.39	$2.76	$1.80	$0.98
Total Capital	9,390	9,288	8,835	8,770	8,743	8,580	8,347	8,514	8,580	8,074	8,003
Total Debt	3,363	3,390	2,932	2,556	2,555	2,735	2,789	2,733	2,971	2,769	2,912
Total Long-Term Debt	3,347	3,345	2,137	2,136	2,555	2,735	2,734	2,733	2,733	2,733	2,732
Net Debt	1,723	1,886	967	708	637	981	1,270	1,372	1,533	1,521	1,641
Capital Expenditures (CapEx)	97	93	92	103	90	84	81	57	76	70	82
Debt-free, Cash-free Net Working Capital (DFCFNWC)	787	780	883	994	973	993	996	1,108	1,130	900	891
Debt-free Net Working Capital (DFNWC)	2,254	2,109	2,662	2,665	2,721	2,583	2,325	2,283	2,380	1,953	1,968
Net Working Capital (NWC)	2,238	2,064	1,867	2,245	2,721	2,583	2,270	2,283	2,142	1,917	1,788
Net Nonoperating Expense (NNE)	7.80	6.13	-8.22	-9.06	-16	-14	0.84	4.81	14	13	12
Net Nonoperating Obligations (NNO)	1,723	1,886	967	708	637	981	1,270	1,372	1,533	1,521	1,641
Total Depreciation and Amortization (D&A)	72	69	63	63	62	62	71	71	67	73	80
Debt-free, Cash-free Net Working Capital to Revenue	12.05%	11.98%	13.59%	15.08%	14.45%	14.53%	14.24%	15.74%	16.31%	13.14%	13.38%
Debt-free Net Working Capital to Revenue	34.50%	32.40%	40.97%	40.43%	40.40%	37.80%	33.24%	32.43%	34.34%	28.52%	29.55%
Net Working Capital to Revenue	34.26%	31.71%	28.74%	34.06%	40.40%	37.80%	32.46%	32.43%	30.91%	27.99%	26.85%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.12	$1.23	$0.97	$1.05	$1.19	$1.63	$0.38	$1.02	$1.19	$1.23	$1.10
Adjusted Weighted Average Basic Shares Outstanding	285M	290M	290M	293M	293M	294M	294M	296M	296M	299M	298M
Adjusted Diluted Earnings per Share	$1.11	$1.23	$0.97	$1.05	$1.18	$1.60	$0.38	$1.02	$1.19	$1.24	$1.10
Adjusted Weighted Average Diluted Shares Outstanding	287M	291M	291M	293M	294M	296M	295M	297M	297M	300M	299M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	285.10M	285.60M	287.33M	291.76M	293.06M	293.00M	292.59M	295.38M	295.70M	296.07M	296.04M
Normalized Net Operating Profit after Tax (NOPAT)	326	357	274	299	332	286	112	307	366	381	341
Normalized NOPAT Margin	19.38%	21.00%	17.35%	19.00%	20.00%	16.92%	6.69%	17.87%	20.83%	20.60%	19.83%
Pre Tax Income Margin	21.83%	23.57%	21.74%	23.78%	24.31%	24.88%	7.89%	21.96%	23.35%	24.61%	23.11%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	13.57	12.78	15.73	18.75	18.50	19.32	5.96	16.21	17.04	20.57	21.79
NOPAT to Interest Expense	11.64	11.16	12.44	14.95	15.07	20.97	4.66	12.78	14.63	16.56	17.93
EBIT Less CapEx to Interest Expense	10.11	9.88	11.55	13.60	14.41	15.50	2.58	13.83	14.00	17.52	17.47
NOPAT Less CapEx to Interest Expense	8.17	8.25	8.26	9.80	10.98	17.16	1.29	10.41	11.59	13.52	13.61
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	21.92%	21.26%	19.25%	21.74%	21.60%	21.37%	23.04%	19.02%	19.20%	19.94%	18.60%
Augmented Payout Ratio	120.41%	110.47%	82.59%	73.67%	62.06%	67.74%	78.64%	64.77%	77.17%	110.77%	104.44%

Frequently Asked Questions About Agilent Technologies' Financials

When does Agilent Technologies's fiscal year end?

According to the most recent income statement we have on file, Agilent Technologies' financial year ends in October. Their financial year 2024 ended on October 31, 2024.

How has Agilent Technologies' net income changed over the last 9 years?

Agilent Technologies' net income appears to be on an upward trend, with a most recent value of $1.29 billion in 2024, rising from $401 million in 2015. The previous period was $1.24 billion in 2023. See where experts think Agilent Technologies is headed by visiting Agilent Technologies' forecast page.

What is Agilent Technologies's operating income?

Agilent Technologies's total operating income in 2024 was $1.49 billion, based on the following breakdown:

Total Gross Profit: $3.54 billion
Total Operating Expenses: $2.05 billion

How has Agilent Technologies revenue changed over the last 9 years?

Over the last 9 years, Agilent Technologies' total revenue changed from $4.04 billion in 2015 to $6.51 billion in 2024, a change of 61.2%.

How much debt does Agilent Technologies have?

Agilent Technologies' total liabilities were at $5.95 billion at the end of 2024, a 20.9% increase from 2023, and a 79.8% increase since 2015.

How much cash does Agilent Technologies have?

In the past 9 years, Agilent Technologies' cash and equivalents has ranged from $1.05 billion in 2022 to $2.68 billion in 2017, and is currently $1.33 billion as of their latest financial filing in 2024.

How has Agilent Technologies' book value per share changed over the last 9 years?

Over the last 9 years, Agilent Technologies' book value per share changed from 12.57 in 2015 to 20.53 in 2024, a change of 63.3%.

Related Companies

This page (NYSE:A) was last updated on 5/21/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Agilent Technologies (A) Financials

Frequently Asked Questions About Agilent Technologies' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Agilent Technologies (A) Financials

Annual Income Statements for Agilent Technologies

Quarterly Income Statements for Agilent Technologies

Annual Cash Flow Statements for Agilent Technologies

Quarterly Cash Flow Statements for Agilent Technologies

Annual Balance Sheets for Agilent Technologies

Quarterly Balance Sheets for Agilent Technologies

Annual Metrics And Ratios for Agilent Technologies

Quarterly Metrics And Ratios for Agilent Technologies

Frequently Asked Questions About Agilent Technologies' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools